Banning Foreign Pharmacies from Sponsored Search: The Online Consumer Response
NBER Working Paper No. 20088
Increased competition from the Internet has raised concerns for the quality of online prescription drugs. Given the illegality of importing unapproved prescription drugs into the U.S. and the pressure from the Department of Justice, Google agreed to ban pharmacies non-certified by the National Association of Boards of Pharmacy (NABP) from sponsored search listings. We study how the ban on non-NABP-certified pharmacies from sponsored search affects consumer search on the Internet. Using click-through data from comScore, we find that non-NABP-certified pharmacies receive fewer clicks after the ban, and this effect is heterogeneous. In particular, pharmacies not certified by the NABP, but certified by other sources (other-certified sites), experience a reduction in total clicks, and some of their lost paid clicks are replaced by organic clicks. In contrast, pharmacies not certified by any of the four major certification agencies suffer a greater reduction in both paid and organic clicks. These results suggest that the ban has increased the search cost for other-certified sites, but at least some consumers overcome the search cost by switching from paid to organic links. In addition to search cost, the ban may have increased concerns for uncertified sites and discouraged consumers from reaching them via both paid and organic links.
You may purchase this paper on-line in .pdf format from SSRN.com ($5) for electronic delivery.
This paper was revised on August 26, 2015
Document Object Identifier (DOI): 10.3386/w20088
Users who downloaded this paper also downloaded these: